packageUbrogepant

ubrogepant

Extends from Pharmacolibrary.Interfaces.PartialSubstance (Identity and physicochemical constants of one drug (Drugs.Substances)).

Information

Ubrogepant is a CGRP receptor antagonist used for the acute treatment of migraine headache. It is an approved medicine, mainly used in the United States; it is not authorised in the European Union.

Summary written by glm-5.3-flash from Wikidata Q27273878 and the WHO ATC classification; not checked by a person.

name:ubrogepant
ATC codes:N02CD04
DrugBank:DB15328
PubChem CID:68748835
Wikidata:Q27273878
formula:C29H26F3N5O3
molar mass:549.553 g/mol (PubChem CID 68748835)
logP:3.1 (Drugs.Common 25.09, not verified)

Parameters

TypeNameDefaultDescription
Stringname (from PartialSubstance)""INN / common name
String[:]atcCodes (from PartialSubstance)fill("", 0)all WHO ATC codes of the drug
StringdrugbankId (from PartialSubstance)""e.g. DB00758
StringpubchemCid (from PartialSubstance)""PubChem compound id
StringchebiId (from PartialSubstance)""ChEBI id (number)
StringwikidataId (from PartialSubstance)""e.g. Q410238
Stringformula (from PartialSubstance)""molecular formula
Modelica.Units.SI.MolarMassM (from PartialSubstance)0molar mass; 0 = unknown
ReallogP (from PartialSubstance)Modelica.Constants.infoctanol-water partition coefficient (log10); inf = unknown